{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:46:12Z","timestamp":1793490372689,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["63375"],"award-info":[{"award-number":["63375"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108237","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T16:09:39Z","timestamp":1634141379000},"page":"108237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PB","title":["Nanocurcumin supplementation ameliorates Behcet\u2019s disease by modulating regulatory T cells: A randomized, double\u2010blind, placebo\u2010controlled trial"],"prefix":"10.1016","volume":"101","author":[{"given":"Samaneh","family":"Abbasian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojin","family":"Farzaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Motavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Hajialilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2021.108237_b0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"The Journal of dermatology"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2021.108237_b0010","first-page":"S53","article-title":"The lumps and bumps of Beh\u00e7et's syndrome","volume":"3","author":"Yazici","year":"2004","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0015","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14397595.2013.879414","article-title":"IL-22-secreting Th22 and IFN-\u03b3-secreting Th17 cells in Beh\u00e7et's disease","volume":"24","author":"Aktas Cetin","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","article-title":"Once a Treg, always a Treg?","volume":"259","author":"Sawant","year":"2014","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/cmi.2015.12","article-title":"Regulatory T cells turn pathogenic","volume":"12","author":"Guo","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2021.108237_b0030","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1002\/jcp.28042","article-title":"mTOR Signaling pathway as a master regulator of memory CD8+T-cells, Th17, and NK cells development and their functional properties","volume":"234","author":"Rostamzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2021.108237_b0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.108237_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et's disease","volume":"233","author":"Hamzaoui","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0714.2011.01061.x","article-title":"Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Beh\u00e7et's disease and recurrent aphthous ulcerations","volume":"41","author":"Pekiner","year":"2012","journal-title":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology"},{"issue":"4 Suppl 45","key":"10.1016\/j.intimp.2021.108237_b0050","first-page":"S107","article-title":"Paradoxical high regulatory T cell activity in Beh\u00e7et's disease","volume":"25","author":"Hamzaoui","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5 Suppl 42","key":"10.1016\/j.intimp.2021.108237_b0055","first-page":"S71","article-title":"CD4+CD25+ regulatory T cells in patients with Beh\u00e7et's disease","volume":"24","author":"Hamzaoui","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108237_b0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et disease","volume":"128","author":"Geri","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/s10165-008-0064-x","article-title":"Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack","volume":"18","author":"Nanke","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0070","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cmi.2015.10","article-title":"FOXP3+ regulatory T cells and their functional regulation","volume":"12","author":"Li","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108237_b0080","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2017.08.001","article-title":"The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease","volume":"16","author":"Qiao","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2021.108237_b0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Beh\u00e7et's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2021.108237_b0090","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1002\/jcb.26809","article-title":"Hypermethylation of IL-10 gene is responsible for its low mRNA expression in Beh\u00e7et's disease","volume":"119","author":"Alipour","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7192","key":"10.1016\/j.intimp.2021.108237_b0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.108237_b0110","first-page":"1","article-title":"MicroRNAs in autoimmune diseases","volume":"2014","author":"Qu","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"12","key":"10.1016\/j.intimp.2021.108237_b0115","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.4049\/jimmunol.166.12.7282","article-title":"A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood","volume":"166","author":"Yamagiwa","year":"2001","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.108237_b0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2010.06.009","article-title":"Altered miRNA expression in T regulatory cells in course of multiple sclerosis","volume":"226","author":"De Santis","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2021.108237_b0125","series-title":"Cochrane Database of Systematic Reviews: Reviews","author":"Taylor","year":"2014"},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Beh\u00e7et's disease\u2013an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.108237_b0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-0-387-46401-5_14","article-title":"Immunomodulation by curcumin","volume":"595","author":"Gautam","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108237_b0140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/1750-3841.13647","article-title":"Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9","volume":"82","author":"Cai","year":"2017","journal-title":"J. Food Sci."},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/nu11051004","article-title":"Curcumin in Autoimmune and Rheumatic Diseases","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2021.108237_b0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-0-387-46401-5_19","article-title":"Curcumin and autoimmune disease","volume":"595","author":"Bright","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5114\/ceji.2015.56970","article-title":"Treatment of low doses curcumin could modulate Th17\/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients","volume":"40","author":"Handono","year":"2015","journal-title":"Central-European Journal of immunology"},{"issue":"7","key":"10.1016\/j.intimp.2021.108237_b0160","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1002\/jcb.28488","article-title":"Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function","volume":"120","author":"Hajialilo","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jcb.28901","article-title":"The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial","volume":"121","author":"Ahmadi","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08923973.2018.1474921","article-title":"Curcumin reduces the expression of interleukin 1\u03b2 and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease","volume":"40","author":"Palizgir","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108237_b0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"key":"10.1016\/j.intimp.2021.108237_b0180","series-title":"In: Proceedings of the American College of Rheumatology Meeting","article-title":"on behalf International Team for the Revision of the International Criteria for Behcet\u2019s Disease, \u201cEvaluation and Revision of the International Study Group Criteria for Beh\u00e7et\u2019s Disease\u201d","author":"Davatchi","year":"2007"},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Behcet's disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2021.108237_b0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1534735415622013","article-title":"B-Cell Disorders and Curcumin","volume":"16","author":"Golombick","year":"2017","journal-title":"Integrative cancer therapies"},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0200","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/ijms17060969","article-title":"Enhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured Macrophages","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2021.108237_b0205","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3390\/molecules20023020","article-title":"Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-\u03b3 production: benefits of omega-3 with curcumin against cancer","volume":"20","author":"Fiala","year":"2015","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0210","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3892\/mmr.2013.1695","article-title":"Effects and mechanisms of curcumin and basil polysaccharide on the invasion of SKOV3 cells and dendritic cells","volume":"8","author":"Lv","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.108237_b0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fitote.2013.02.014","article-title":"Curcumin attenuates allergic airway inflammation by regulation of CD4+CD25+ regulatory T cells (Tregs)\/Th17 balance in ovalbumin-sensitized mice","volume":"87","author":"Ma","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.intimp.2021.108237_b0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.intimp.2021.108237_b0225","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/eji.200939052","article-title":"Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells","volume":"39","author":"Cong","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108237_b0230","doi-asserted-by":"crossref","first-page":"e62300","DOI":"10.1371\/journal.pone.0062300","article-title":"Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-\u03b21-mediated generation of regulatory T cells at late phase","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2021.108237_b0235","doi-asserted-by":"crossref","first-page":"e67171","DOI":"10.1371\/journal.pone.0067171","article-title":"Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells","volume":"8","author":"Park","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2021.108237_b0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/injr.injr_95_16","article-title":"Immune modulation effects of curcumin in pristane-induced lupus mice","volume":"12","author":"Kalim","year":"2017","journal-title":"Indian Journal of Rheumatology"},{"issue":"11","key":"10.1016\/j.intimp.2021.108237_b0245","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jnutbio.2011.10.002","article-title":"Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis","volume":"23","author":"Kanakasabai","year":"2012","journal-title":"The Journal of nutritional biochemistry"},{"key":"10.1016\/j.intimp.2021.108237_b0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","volume":"327","author":"Dolati","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108237_b0255","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1002\/jcp.26301","article-title":"Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Dolati","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108237_b0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108237_b0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.22631\/rr.2017.69997.1026","article-title":"Upregulation of transforming growth factor-B1 gene in ankylosing spondylitis patients","volume":"2","author":"Vaez","year":"2017","journal-title":"Rheumatology Research"},{"issue":"5","key":"10.1016\/j.intimp.2021.108237_b0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production","volume":"9","author":"Xie","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108237_b0275","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1902\/jop.2016.150722","article-title":"Effect of Curcumin on Systemic T Helper 17 Cell Response; Gingival Expressions of Interleukin-17 and Retinoic Acid Receptor-Related Orphan Receptor \u03b3t; and Alveolar Bone Loss in Experimental Periodontitis","volume":"87","author":"Bak\u0131r","year":"2016","journal-title":"J. Periodontol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:21Z","timestamp":1761586941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":55,"alternative-id":["S1567576921008730"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108237","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocurcumin supplementation ameliorates Behcet\u2019s disease by modulating regulatory T cells: A randomized, double\u2010blind, placebo\u2010controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108237"}}